Overview > MNDcare approach > Information and discussion > For health and community care professionals > National Institute for Health and Clinical Excellence 2001 NICE: Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease

National Institute for Health and Clinical Excellence 2001 NICE: Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease

National Institute for Health and Clinical Excellence, (2001). NICE: Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease.

Free full text access online.

guidance.nice.org.uk/TA20

Referral Pathways

Click on a state or territory.

Or to search using additional criteria visit Referral Pathways.

Disclaimer Copyright MNDcare

Funded by the Australian Government Department of Health and Ageing

MND Australia would like to advise Aboriginal and Torres Strait Islander users that this website may contain images or names of deceased persons.